Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Basis and Translational Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity

NCT04036045 is registered in ClinicalTrials.gov with Connecticut Children's Medical Center as lead sponsor.

NCT NCT04036045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04036045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Basis and Translational Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity
Lead sponsor
Connecticut Children's Medical Center
Phase
Observational
Overall status
Withdrawn
Start date
November 12, 2018
Completion date
March 31, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood cancer